Linganisha mbinu

	Kipimo cha Athari za Fibromyalgia (Fibromyalgia Impact Questionnaire)	Kielelezo cha Ubora wa Maisha wa Madaktari wa Ngozi
Nyanja	Matokeo ya Afya	Matokeo ya Afya
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	1991	1994
Mwanzilishi	Cynthia S. Burckhardt et al.	Andrew Y. Finlay and Gul K. Khan
Aina	Self-report symptom and functional impairment questionnaire	Self-report quality of life questionnaire
Chanzo asilia	Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735.	Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216.
Majina mbadala	FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire	DLQI, Finlay Index, Dermatology Quality of Life
Zinazohusiana	4	3
Muhtasari	The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.	The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology.